While are biopharmaceutical companies after Hanmi Pharm?

While the biopharmaceutical industry has attracted high interests as the Hanmi Pharm’s technology transfers have been on everyone’s lips, a report was out from the securities industry, analyzing biopharmaceutical companies having noticeable pipelines in 2016.

On the 4^th, Daewoo Securities selected Oscotec, Eyegene, GtreeBNT and Genexine as companies to keep an eye on this year.

Among the sugg...